Hsu, D W <br/><br/>
Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.  [electronic resource] 

 -  Journal of neuropathology and experimental neurology  Aug 1997 
 - 857-65 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3069 
<br/><br/><label>Standard No.: </label>10.1097/00005072-199708000-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Antibodies, Monoclonal--immunology<br/>Female<br/>Glioma--immunology<br/>Humans<br/>Immunohistochemistry<br/>Ki-67 Antigen--immunology<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Survival Analysis